Evonik invests in Japanese silica capacity
Chemicals firm Evonik has expanded its capacity in Japan to cope with high demands for specialty silica, used in various drugmaking operations.
Archives for September 7, 2014
Charles River to lay off up to 30 employees following NCI contract termination
Early phase CRO (contract research organization) Charles River Laboratories will lay off between 26 and 30 employees following the US National Cancer Institute’s decision to terminate a contract in which the company supplied rodent models for cancer...
Synthon sells Czech plant to Mercachem in API consolidation move
Synthon has consolidated its Czech API capabilities through the sale of a laboratory and pilot scale plant in Prague to CRO Mercachem.
MHRA and Novartis lead consortium to develop adverse drug reaction app
The drug industry and regulators have teamed up to develop a smartphone app to make the gathering and reporting of adverse drug reactions easier.
ISPE offers preview to drug shortages prevention plan
The International Society for Pharmaceutical Engineering (ISPE) last week offered up a preview to its plan to help manufacturers avoid or mitigate drug shortages due to manufacturing or quality issues.
Biologics trials: the ‘stretched’ global supply chain
The high cost and complexity of producing biopharmaceuticals for clinical trials limits supplies and makes effective logistics even more important than for small molecule studies says Almac.
Investors losing interest in CROS? Have your say in our poll
Quintiles' investor day: Has Private Equity called time on the CRO sector?
An under-attended investor day at Quintiles, the world’s largest CRO, is indicative of waning interest in the clinical sector according to a William Blair analyst.